1. Home
  2. MKC vs HALO Comparison

MKC vs HALO Comparison

Compare MKC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McCormick & Company Incorporated

MKC

McCormick & Company Incorporated

HOLD

Current Price

$55.19

Market Cap

13.7B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$108.00

Market Cap

11.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKC
HALO
Founded
1889
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
11.2B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
MKC
HALO
Price
$55.19
$108.00
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$67.00
$78.64
AVG Volume (30 Days)
2.6M
2.3M
Earning Date
03-31-2026
05-05-2026
Dividend Yield
3.80%
N/A
EPS Growth
0.34
N/A
EPS
4.33
3.11
Revenue
$6,840,300,000.00
$151,862,000.00
Revenue This Year
$16.24
$28.24
Revenue Next Year
$3.71
$12.56
P/E Ratio
$12.58
$35.15
Revenue Growth
1.73
N/A
52 Week Low
$44.82
$61.23
52 Week High
$72.41
$109.55

Technical Indicators

Market Signals
Indicator
MKC
HALO
Relative Strength Index (RSI) 53.83 78.98
Support Level $49.91 $67.12
Resistance Level $54.41 N/A
Average True Range (ATR) 1.28 3.46
MACD 0.00 0.45
Stochastic Oscillator 47.03 97.44

Price Performance

Historical Comparison
MKC
HALO

About MKC McCormick & Company Incorporated

In its 135-plus-year history, McCormick has become the leading global manufacturer of spices, herbs, extracts, seasonings, and other flavorings. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula. This mix will be complemented by the pending addition of Unilever's food brands, primarily Knorr cooking aids and Hellmann's mayonnaise. After the deal close, the combined business is slated to generate 70% of sales from consumers and 30% from restaurants and other packaged food and beverage manufacturers. Around 40% of sales are slated to come from faster-growing emerging markets, with Europe (23%) and North America (36%) accounting for the remainder.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: